These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11464867)

  • 1. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties.
    Gross N; Balmas K; Beretta Brognara C
    Med Pediatr Oncol; 2001 Jan; 36(1):139-41. PubMed ID: 11464867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N; Balmas Bourloud K; Brognara CB
    Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A; Takahashi K; Cutler M; Tanabe KK
    Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
    Takahashi K; Stamenkovic I; Cutler M; Saya H; Tanabe KK
    Oncogene; 1995 Dec; 11(11):2223-32. PubMed ID: 8570172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
    Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
    J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells.
    Nakano T; Matsui T; Ota T
    Anticancer Res; 1996; 16(6B):3577-84. PubMed ID: 9042224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin sulfate addition to CD44H negatively regulates hyaluronan binding.
    Ruffell B; Johnson P
    Biochem Biophys Res Commun; 2005 Aug; 334(2):306-12. PubMed ID: 16002044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
    Gao AC; Lou W; Sleeman JP; Isaacs JT
    Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate.
    Takahashi K; Stamenkovic I; Cutler M; Dasgupta A; Tanabe KK
    J Biol Chem; 1996 Apr; 271(16):9490-6. PubMed ID: 8621620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis.
    Nasreen N; Mohammed KA; Hardwick J; Van Horn RD; Sanders K; Kathuria H; Loghmani F; Antony VB
    Oncol Res; 2002; 13(2):71-8. PubMed ID: 12392154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different functions for CD44 proteins in human myelopoiesis.
    Moll J; Khaldoyanidi S; Sleeman JP; Achtnich M; Preuss I; Ponta H; Herrlich P
    J Clin Invest; 1998 Sep; 102(5):1024-34. PubMed ID: 9727071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
    Bajorath J
    Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
    Catterall JB; Jones LM; Turner GA
    Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronate and its receptors in bone marrow.
    Schade UM; Nehmann N; Horny HP; Prehm P; Delpech B; Krüger WH; Zander AR; Schumacher U
    Acta Histochem; 2006; 108(2):141-7. PubMed ID: 16713618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.